Canada · Health Canada Drug Product Database

NRA-SITAGLIPTIN TABLETS

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 106870
DIN: 02566176
Form: Tablet
Company as listed by source: NORA PHARMA INC
Source status: Approved (2026-02-25)
Source last updated: 2026-02-26

Source-listed ingredients

SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) — 100 MG

These values do not establish equivalence or a dose recommendation.

Packages

Package details are not available in this snapshot.

Source and coverage

Open Health Canada Drug Product Database →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse Canada records →